During the past decade, Sutter Gould Medical Foundation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Gould Medical Foundation" #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Amgen" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Gould Medical Foundation" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Gould Medical Foundation" are "Atrial Fibrillation" (2 trials), "Anemia, Iron Deficiency" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Sutter Gould Medical Foundation" in a lesser frequency.

Most popular intervention types in "Sutter Gould Medical Foundation" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials), "Bortezomib" (1 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Gould Medical Foundation" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Gould Medical Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sutter Gould Medical Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Gould Medical Foundation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".